The DCNN works to advance our understanding of neurodegenerative disease, with the expectation that such advances will offer opportunities for leveraging acquired mechanistic knowledge into substantive opportunities for therapy development.
The Duke Center for Neurodegeneration and Neurotherapeutics (DCNN) is made of an interdisciplinary team of experts from across Duke that works to advance our understanding of neurodegenerative disease, with the expectation that such advances will offer opportunities for leveraging acquired mechanistic knowledge into substantive opportunities for therapy development. Read more about the DCNN and its work here.